16 results
424B5
GLUE
Monte Rosa Therapeutics Inc
26 Oct 23
Prospectus supplement for primary offering
4:55pm
scaffolds with favorable binding affinities for the E3 ubiquitin ligase cereblon, and representing ever increasing chemical diversity.
Degron encyclopedia
8-K
EX-99.4
GLUE
Monte Rosa Therapeutics Inc
17 Oct 23
Monte Rosa to receive an upfront payment of $50 million and potential future payments exceeding $2 billion
7:55am
complex formation involves: MGD-ligase interactions MGD-neosubstrate interactions Ligase-neosubstrate interactions MGD MGD Create library diversity … . Internal space comprises Diversity Library, containing glutarimide and MW < 500. Teaching Cereblon New Tricks Expanding the degradable proteome by AI
PRE 14A
fqfx4ea t8
12 Apr 23
Preliminary proxy
4:07pm
S-3
1hvyy9r961
1 Jul 22
Shelf registration
5:01pm
DEF 14A
4rsx9v1
27 Apr 22
Definitive proxy
4:10pm
10-K
2prg7di9ptr8t 34u77
29 Mar 22
Annual report
4:15pm
8-K
EX-99.1
qr5gq5
10 Jan 22
Regulation FD Disclosure
7:31am
424B4
2l6 fwq9jx2rlmyk
25 Jun 21
Prospectus supplement with pricing info
6:08am
S-1/A
b356i93iz52xzbu j8
9 Jun 21
IPO registration (amended)
4:51pm
S-1
88ynks
4 Jun 21
IPO registration
9:07am
DRS/A
mce2hlf 51ic2nrhj9k
21 May 21
Draft registration statement (amended)
12:00am
DRS
b4fkvh3
19 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next